Finance

Lists
Why is LDOS down 2.09%?
Dive Deeper
LDOS:NYSE
Leidos Holdings Inc
$122.21
-2.09%
(-2.61) 1D
$122.21
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LDOS...
Open
$125.45
High
$127.50
Low
$121.90
Mkt. cap
14.91B
Avg. vol.
1.03M
Volume
1.50M
Dividend
1.47%
Quarterly dividend
$0.45
Ex-dividend date
Jun 15, 2026
P/E ratio
10.94
52-wk high
$205.00
52-wk low
$98.86
EPS
$11.17
Beta
0.55
Shares outstanding
122.00M
No. of employees
50K
Open
$125.45
High
$127.50
Low
$121.90
Mkt. cap
14.91B
Avg. vol.
1.03M
Volume
1.50M
Dividend
1.47%
Quarterly dividend
$0.45
Ex-dividend date
Jun 15, 2026
P/E ratio
10.94
52-wk high
$205.00
52-wk low
$98.86
EPS
$11.17
Beta
0.55
Shares outstanding
122.00M
No. of employees
50K
News stories
From web sources and news partners
Profile
Leidos Holdings, Inc. is an American defense, aviation, information technology, and biomedical research company headquartered in Reston, Virginia, that provides scientific, engineering, systems integration, and technical services. Founded as Science Applications International Corporation, Leidos merged with Lockheed Martin's IT sector, Information Systems & Global Solutions, in August 2016 to create the defense industry’s largest IT services provider. The Leidos-Lockheed Martin merger is one of the biggest transactions thus far in the consolidation of the defense sector. Leidos contracts extensively with the Department of Defense, the Department of Homeland Security, and the Intelligence Community, as well as other U.S. government agencies and select commercial markets. Wikipedia
About Leidos Holdings Inc
CEOThomas A. Bell
Employees50K
FoundedJun 1969
Headquarters-
SectorIndustrials
IndustryService
Websiteleidos.com
Analyst ratings
Based on 9 analysts giving stock ratings to LDOS in the past 3 months
Hold
Buy
2
Hold
7
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for LDOS in the last 3 months.
Highest
Current $122.21
$170.00 (+39.10%)
Average
$142.22 (+16.37%)
Lowest
$122.00 (-0.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Godyn
Citi
Buy
Maintained
$163.00
+33.4%
11/10/2026
Noah Poponak
Goldman Sachs
Hold
Maintained
$122.00
-0.2%
11/08/2026
Sheila Kahyaoglu
Jefferies
Hold
Maintained
$135.00
+10.5%
11/08/2026
Kenneth Herbert
RBC Capital
Buy
Maintained
$170.00
+39.1%
11/03/2026
Jonathan Siegmann CFA
Stifel Nicolaus
Hold
Reiterated
$138.00
+12.9%
11/04/2026
Seth Seifman
J.P. Morgan
Hold
Downgraded
$142.00
+16.2%
10/08/2026
Gautam Khanna
TD Cowen
Hold
Maintained
$130.00
+6.4%
10/05/2026
Gavin Parsons
UBS
Hold
Maintained
$145.00
+18.6%
09/28/2026
Mariana Perez Mora
Bank of America Securities
Hold
Reiterated
$135.00
+10.5%
09/18/2026
Ronald Epstein
Bank of America Securities
Hold
Reiterated
$135.00
+10.5%
09/18/2026
David E. Strauss
Wells Fargo
Hold
Maintained
$165.00
+35%
08/14/2026
Tobey Sommer
Truist Financial
Buy
Reiterated
$160.00
+30.9%
08/05/2026
Peter Arment
Robert W. Baird
Hold
Maintained
-
-
08/05/2026
Louie DiPalma
William Blair
Hold
Maintained
-
-
08/04/2026
Matthew Akers
Exane BNP Paribas
Buy
Initiated
$165.00
+35%
05/27/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$3.62 / $3.03
+19.37%beat
Revenue / Est. (USD)
4.63B / 4.71B
-1.78%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jan 2026
Apr 2026
Jul 2026
Oct 2026
Revenue
4.21B
4.40B
4.56B
4.63B
Cost of goods sold
3.47B
3.64B
3.74B
3.81B
Cost of revenue
3.47B
3.64B
3.74B
3.81B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
266.00M
223.00M
283.00M
262.00M
Operating expense
266.00M
223.00M
283.00M
262.00M
Total operating expenses
3.73B
3.86B
4.02B
4.07B
Operating income
473.00M
538.00M
534.00M
558.00M
Other non operating income
4.00M
-24.00M
6.00M
-4.00M
EBT including unusual items
429.00M
429.00M
451.00M
482.00M
EBT excluding unusual items
438.00M
464.00M
478.00M
494.00M
Income tax expense
94.00M
94.00M
95.00M
69.00M
Effective tax rate
21.91%
21.91%
21.06%
14.32%
Other operating expenses
-
-
-
-
Net income
327.00M
328.00M
354.00M
410.00M
Net profit margin
7.77%
7.45%
7.77%
8.86%
Earnings per share
2.76
3.13
3.26
3.62
Interest and investment income
-
-
-
-
Interest expense
-48.00M
-55.00M
-69.00M
-67.00M
Net interest expenses
-48.00M
-55.00M
-69.00M
-67.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
548.00M
610.00M
615.00M
634.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps